1. 607TiPBIG BANG study: A multicenter phase II study of the MEK inhibitor binimetinib + BRAF inhibitor encorafenib + anti-EGFR antibody cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer (EPOC 1703). (23rd October 2018) Authors: Kotani, D; Bando, H; Masuishi, T; Komatsu, Y; Yamaguchi, K; Nakajima, T E; Satoh, T; Nishina, T; Esaki, T; Nomura, S; Sakamoto, S; Iida, S; Matsuda, S; Yonemura, M; Fuse, N; Sato, A; Fujii, S; Ebi, H; Ohtsu, A; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 608TiPBRAVERY study: A multicenter phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer (EPOC1701). (23rd October 2018) Authors: Masuishi, T; Taniguchi, H; Kotani, D; Bando, H; Komatsu, Y; Yamaguchi, K; Nakajima, T E; Satoh, T; Nishina, T; Esaki, T; Wakabayashi, M; Nomura, S; Sakamoto, S; Ono, H; Hirano, N; Fujishiro, N; Fuse, N; Sato, A; Ohtsu, A; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 623PDThe nationwide cancer genome screening project in Japan, SCRUM Japan GISCREEN: Efficient identification of cancer genome alterations in advanced biliary tract cancer. (23rd October 2018) Authors: Morizane, C; Komatsu, Y; Takahashi, H; Ueno, M; Furuse, J; Kudo, T; Itoh, S; Shimizu, S; Nakamura, K; Kamata, K; Ohtsubo, K; Mizukami, T; Kagawa, Y; Nomura, S; Kuwata, T; Fujii, S; Okamoto, W; Shitara, K; Ohtsu, A; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 784TiPPhase III KEYNOTE-585 study of chemotherapy (Chemo) + pembrolizumab (Pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (Pts) with gastric or gastroesophageal junction (G/GEJ) cancer. (23rd October 2018) Authors: Bang, Y-J; Van Cutsem, E; Fuchs, C S; Ohtsu, A; Tabernero, J; Ilson, D H; Hyung, W J; Strong, V E; Goetze, T O; Yoshikawa, T; Tang, L H; Hwang, P M T; Adelberg, D; Shitara, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of aldehyde dehydrogenase 2gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients. (1st August 2000) Authors: Muto, M; Hitomi, Y; Ohtsu, A; Ebihara, S; Yoshida, S; Esumi, H Journal: Gut Issue: Volume 47(2000)Supplement 2 Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis?. Issue 6 (1st December 1999) Authors: Konishi, K; Fujii, T; Boku, N; Kato, S; Koba, I; Ohtsu, A; Tajiri, H; Ochiai, A; Yoshida, S Journal: Gut Issue: Volume 45:Issue 6(1999) Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LBA-005KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer. (24th June 2018) Authors: Shitara, K; Özgüroğlu, M; Bang, Y J; Di Bartolomeo, M; Mandalà, M; Ryu, M H; Fornaro, L; Olesiński, T; Caglevic, C; Chung, H; Muro, K; Gökkurt, E; Mansoor, W; McDermott, R; Schacham-Shmueli, E; Chen, X; Kang, S P; Mayo, C; Ohtsu, A; Fuchs, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. O-028Long-term effect of peripheral sensory neuropathy (PSN) of 3 or 6 months oxaliplatin-based adjuvant chemotherapy for stage III colon cancer: ACHIEVE as part of the IDEA collaboration. (20th June 2018) Authors: Takeuchi, S; Yoshino, T; Yamanaka, T; Kotaka, M; Manaka, D; Eto, T; Hasegawa, J; Takagane, A; Nakamura, M; Kato, T; Munemoto, Y; Bando, H; Taniguchi, H; Gamoh, M; Shiozawa, M; Saji, S; Maehara, Y; Mizushima, T; Ohtsu, A; Mori, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-096A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress. (20th June 2018) Authors: Bang, Y; Van Cutsem, E; Fuchs, C; Ohtsu, A; Tabernero, J; Ilson, D; Hyung, W; Strong, V; Goetze, T; Yoshikawa, T; Tang, L; Hwang, P; Shitara, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. (16th November 2017) Authors: Yoshino, T; Arnold, D; Taniguchi, H; Pentheroudakis, G; Yamazaki, K; Xu, R -H; Kim, T W; Ismail, F; Tan, I B; Yeh, K -H; Grothey, A; Zhang, S; Ahn, J B; Mastura, M Y; Chong, D; Chen, L -T; Kopetz, S; Eguchi-Nakajima, T; Ebi, H; Ohtsu, A Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗